The what and the why for R/Pharma

By design, R / Pharma is deliberately a smaller conference in terms of attendance in order to encourage maximum opportunities for direct interaction with speakers. In 2018 and 2019 the conference was held in the Tsai Auditorium at the Center for Government and International Studies, Harvard University and capped at 150 attendees. The conference was run as a free event. Invitations were based on committee membership and advisory support, speaker acceptance, academic/student and diversity.

The conference has been run with single track consisting of keynotes from renowned industry practitioners to key R developers to leading academics. In addition there were a number of pre-conference workshops and full-length presentations as well as a number of shorter, highly-energetic lightning talks.

For 2020 we are taking a hiatus from holding the meeting at Harvard and will be running a virtual conference. More details will follow.

Our entire event is a community-lead effort and 100% volunteer run. The event is vendor neutral and very much an academic conference. Harvard has been very helpful in hosting the event.

R/Pharma is an ISC working group under the R Consortium. The conference is a relatively small, scientifically & industry oriented, collegial event focused on the use of R in the development of pharmaceuticals. The conference covers topics including reproducible research, regulatory compliance and validation, safety monitoring, clinical trials, drug discovery, research & development, PK/PD/pharmacometrics, genomics, diagnostics, immunogenicity and more. All are discussed within the context of using R as a primary tool within the drug development process. The conference showcases the current use of R that is helping to drive biomedical research, drug discovery & development, and clinical initiatives. (Note that topics related to the use of R in hospitals/clinics for patient care by clinicians, doctors, and researchers is the focus of R/Medicine.)

R/Pharma is dedicated to providing a harassment-free conference experience for everyone regardless of gender, sexual orientation, disability or any feature that distinguishes human beings. For more information, please see the R Consortium code of conduct.